Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
152M
-
Number of holders
-
333
-
Total 13F shares, excl. options
-
36M
-
Shares change
-
+250K
-
Total reported value, excl. options
-
$5.33B
-
Value change
-
+$35.7M
-
Put/Call ratio
-
3.66
-
Number of buys
-
147
-
Number of sells
-
-153
-
Price
-
$147.95
Significant Holders of BIO-TECHNE Corp - COMMON STOCK (TECH) as of Q2 2018
367 filings reported holding TECH - BIO-TECHNE Corp - COMMON STOCK as of Q2 2018.
BIO-TECHNE Corp - COMMON STOCK (TECH) has 333 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 36M shares
of 152M outstanding shares and own 23.64% of the company stock.
Largest 10 shareholders include BlackRock Inc. (3.78M shares), VANGUARD GROUP INC (3.28M shares), BROWN CAPITAL MANAGEMENT LLC (1.98M shares), ATLANTA CAPITAL MANAGEMENT CO L L C (1.9M shares), Neuberger Berman Group LLC (1.58M shares), BAMCO INC /NY/ (1.51M shares), JANUS HENDERSON GROUP PLC (1.39M shares), Mairs & Power INC (1.29M shares), STATE STREET CORP (943K shares), and Jackson Square Partners, LLC (819K shares).
This table shows the top 333 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.